Approach to treating cystic fibrosis pulmonary exacerbations varies widely across us CF care centers

Pediatric Pulmonology

Volumn 46, Issue 9, 2011, Pages 870-881

  Kraynack, Nathan C ^a   Gothard, M David ^a   Falletta, Lynn M ^b   McBride, John T ^a  

^a AKRON CHILDREN'S HOSPITAL   (United States)

^b KENT STATE UNIVERSITY   (United States)

Author keywords

clinical vignettes; cystic fibrosis; pulmonary exacerbations; treatment variation

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; CLINICAL PRACTICE; COUGHING; CYSTIC FIBROSIS; DISEASE EXACERBATION; E-MAIL; HOSPITAL; HUMAN; NURSE; OXYGEN SATURATION; PHYSICIAN; PRIORITY JOURNAL; PULMONARY EXACERBATION; SPUTUM; TREATMENT PLANNING; UNITED STATES; VIGNETTE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; COUGH; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE SURVEYS; HUMANS; LUNG DISEASES; MALE; OXYGEN; RESPIRATORY SOUNDS; SPUTUM; UNITED STATES; YOUNG ADULT;

EID: 80051796005     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21442     Document Type: Article

References (25)

1. Konstan M, Berger M,. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol 1997; 24: 137-142. (Pubitemid 27450731)
2. Wood R, Leigh M,. What is a "pulmonary exacerbation" in cystic fibrosis? J Pediatr 1987; 11: 841-842.
3. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL,. Pseudomonas aeruginosa and other predictors of morbidity and mortality in young children with cystic fibrosis. Pediatr Pulmonol 2002; 34: 91-100. (Pubitemid 34809519)
4. Wat D, Doull I,. Respiratory virus infections in cystic fibrosis. Paediatr Respir Rev 2003; 4: 172-177. (Pubitemid 36987173)
5. Rabin HR, Butler SJ, Wohl ME, Geller DE, Colin AA, Schidlow DV, Johnson CA, Konstan MW, Regelmann WE,. Pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 2004; 37: 400-406. (Pubitemid 38620061)
6. Smyth A,. Update on the treatment of pulmonary exacerbations in cystic fibrosis. Curr Opin Pulm Med 2006; 12: 440-444. (Pubitemid 44624605)
7. Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl ME, Wagener JS, Regelmann WE, Johnson CA,. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr 2007; 151: 134-139.
8. Ferkol T, Rosenfeld M, Milla CE,. Cystic fibrosis pulmonary exacerbations. J Pediatr 2006; 148: 256-264.
9. Goss C, Burns J,. Exacerbations in cystic fibrosis-1: epidemiology and pathogenesis. Thorax 2007; 62: 360-367. (Pubitemid 46580580)
10. Marshall B,. Pulmonary exacerbations in cystic fibrosis: its time to be explicit. Am J Respir Crit Care Med 2004; 169: 781-782. (Pubitemid 38402449)
11. Dakin C, Henry RL, Field P, Morton J,. Defining and exacerbation of pulmonary disease in cystic fibrosis. Pediatr Pulmonol 2001; 31: 436-442. (Pubitemid 32523636)
12. Johnson C, Butler SM, Konstan MW, Morgan W, Wohl ME,. Factors influencing outcomes in cystic fibrosis: a center based analysis. Chest 2003; 123: 20-27. (Pubitemid 36126709)
13. Clinical Practice Guidelines for Cystic Fibrosis. Bethesda, MD: Cystic Fibrosis Foundation; 1997.
14. Rosenfeld M, Emerson J, Williams-Warren J, Pepe M, Smith A, Montgomery AB, Ramsey B,. Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr 2001; 31: 436-442.
15. Blumer JL, Saiman L, Konstan MW, Melnick D,. The efficacy and safety of meropenum and tobramycin vs ceftazidime and tobramycinin the treatment of acute pulmonary exacerbations in patients with cystic fibrosis. Chest 2005; 128: 2336-2346. (Pubitemid 41507577)
16. Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME,. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 1994; 331: 637-642. (Pubitemid 24276863)
17. Flume PA, Mogayzel PJ, Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, Marshall BC,. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med 2009; 180: 802-808.
18. Peabody JW, Luck J, Glassman P, Jain S, Hansen J, Spell M, Lee M,. Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med 2004; 141: 771-780.
19. Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M,. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA 2000; 283: 1715-1722. (Pubitemid 30196212)
20. Ang DC, Thomas K, Kroenke K,. An exploratory study of primary care physician decision making regarding total joint arthroplasty. J Gen Intern Med 2007; 22: 74-79. (Pubitemid 47308788)
21. Webster BS, Courtney TK, Huang YH, MAtz S, Christiani DC,. Physicians initial management of acute low back pain versus evidence-based guidelines. J Gen Intern Med 2005; 20: 1132-1135. (Pubitemid 43110264)
22. Fick DM, Hodo DM, Lawrence F, Inouye SK,. Recognizing delirium superimposed on dementia: assessing nurses' knowledge using case vignettes. J Gerontol Nurs 2007; 33: 40-49.
23. Foster JA, Yawn BP, Maziar A, Jenkins T, Rennard SI, Casebeer L,. Enhancing COPD management in primary Care settings. Med Gen Med 2007; 9: 24.
24. Kraynack NC, McBride JT,. Improving care at cystic fibrosis centers through quality improvement. Semin Respir Crit Care Med 2009; 30: 547-558.
25. Cystic Fibrosis Foundation Annual Registry report. October 2008. Cystic Fibrosis Foundation. Bethesda, MD.